SUSQUEHANNA INTERNATIONAL GROUP, LLP - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 225 filers reported holding BRIDGEBIO PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.6%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$38,285,363
+44.6%
1,451,853
-5.7%
0.01%
+60.0%
Q2 2023$26,473,570
+44.2%
1,539,161
+39.0%
0.01%
+25.0%
Q1 2023$18,360,824
+1266.6%
1,107,408
+528.1%
0.00%
Q4 2022$1,343,536
-57.4%
176,317
-44.4%
0.00%
-100.0%
Q3 2022$3,154,000
-25.6%
317,243
-32.0%
0.00%0.0%
Q2 2022$4,238,000
-4.2%
466,793
+7.1%
0.00%
Q1 2022$4,424,000
-92.8%
435,797
-88.2%
0.00%
-100.0%
Q4 2021$61,504,000
+568.8%
3,687,462
+1779.3%
0.00%
+100.0%
Q3 2021$9,196,000
-11.2%
196,213
+15.5%
0.00%
-50.0%
Q2 2021$10,354,000
-15.6%
169,856
-14.7%
0.00%0.0%
Q1 2021$12,269,000
-25.4%
199,169
-13.9%
0.00%
+100.0%
Q4 2020$16,446,000
+665.3%
231,298
+303.6%
0.00%
Q3 2020$2,149,000
-81.3%
57,304
-83.7%
0.00%
-100.0%
Q2 2020$11,485,000
+29.0%
352,175
+14.7%
0.00%
-33.3%
Q1 2020$8,906,000
+4023.1%
307,105
+2947.3%
0.00%
Q3 2019$216,00010,0780.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$160,016,45665.94%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$819,077,80528.79%
Cormorant Asset Management, LP 4,662,530$122,950,9167.17%
Frazier Life Sciences Management, L.P. 2,725,949$71,883,2754.77%
Octagon Capital Advisors LP 971,639$25,622,1203.94%
M28 Capital Management LP 121,200$3,196,0443.66%
VIKING GLOBAL INVESTORS LP 25,120,991$662,440,5332.69%
BOONE CAPITAL MANAGEMENT LLC 313,381$8,263,8572.61%
Fernwood Investment Management, LLC 235,620$6,213,2992.23%
SOUTHPORT MANAGEMENT, L.L.C. 15,000$395,5502.15%
View complete list of BRIDGEBIO PHARMA INC shareholders